Oestrogen-only users No. of GORD cases OR (95% CI) P | Tibolone users No. of GORD cases OR (95% CI) P | Combined HRT users No. of GORD cases OR (95% CI) P | Progestogen users No. of GORD cases OR (95% CI) P | |
---|---|---|---|---|
PPI | ||||
Hormone | 110 | 21 | 116 | 49 |
Non-hormone | 467 | 467 | 467 | 467 |
OR (95% CI) p | 1.34 (1.03–1.74) 0.027 | 0.76 (0.43–1.37) 0.367 | 1.15 (0.90–1.47) 0.250 | 1.50 (1.01–2.22) 0.044 |
NSAIDs <30d | ||||
Hormone | 22 | 2 | 18 | 10 |
Non-hormone | 81 | 81 | 81 | 81 |
OR (95% CI) p | 1.57 (1.09–2.26) 0.016 | 0.83 (0.34–2.08) 0.700 | 1.57 (1.13–2.19) 0.008 | 1.15 (0.67–1.98) 0.606 |
NSAIDs ≥30d | ||||
Hormone | 56 | 16 | 58 | 24 |
Non-hormone | 200 | 200 | 200 | 200 |
OR (95% CI) p | 2.02 (1.52–2.69) < 0.001 | 2.55 (1.41–4.63) 0.002 | 2.37 (1.82–3.07) < 0.001 | 1.61 (1.05–2.46) 0.029 |
Calcium <30d | ||||
Hormone | 1 | 1 | 1 | 0 |
Non-hormone | 11 | 11 | 11 | 11 |
OR (95% CI) p | 0.97 (0.28–3.35) 0.959 | 2.78 (0.64–12.05) 0.172 | 1.21 (0.41–3.55) 0.732 | 3.60 (1.12–11.56) 0.031 |
Calcium ≥30d | ||||
Hormone | 12 | 2 | 10 | 0 |
Non-hormone | 29 | 29 | 29 | 29 |
OR (95% CI) p | 1.98 (1.12–3.50) 0.019 | 2.9 (0.90–9.43) 0.075 | 1.21 (0.65–2.26) 0.555 | 1.85 (0.59–5.82) 0.293 |
Bisphosphonate <30d | ||||
Hormone | 1 | 0 | 0 | 0 |
Non-hormone | 3 | 3 | 3 | 3 |
OR (95% CI) p | 3.05 (0.70–13.42) 0.139 | - (−) 0.999 | - (−) 0.999 | 1.50 (0.14–15.69) 0.737 |
Bisphosphonate ≥30d | ||||
Hormone | 6 | 2 | 7 | 0 |
Non-hormone | 18 | 18 | 18 | 18 |
OR (95% CI) p | 1.96 (0.94–4.12) 0.074 | 1.70 (0.40–7.19) 0.474 | 2.01 (0.93–4.73) 0.075 | 1.38 (0.29–6.60) 0.685 |